Cargando…
1249. Images vs. C-Reactive Protein Follow-up of Patients with Organ/space Surgical Site Infections
BACKGROUND: End-of-treatment images of infections after intra-abdominal infection could increase costs. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are used to define and predict the evolution of infectious diseases. The aim of this study was to describe clinical outcomes of ad...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808908/ http://dx.doi.org/10.1093/ofid/ofz360.1112 |
_version_ | 1783461851930034176 |
---|---|
author | Garcia Allende, Natalia Freuler, Cristina Victoria Sanchez, Ana Ezcurra, Cecilia Mayer Wolf, Micaela Eliana Iglesias, Debora Paz, Sandra Antezana Trigo, Ingrid Risso Patron, Agustina Rodriguez, Viviana Elizabeth |
author_facet | Garcia Allende, Natalia Freuler, Cristina Victoria Sanchez, Ana Ezcurra, Cecilia Mayer Wolf, Micaela Eliana Iglesias, Debora Paz, Sandra Antezana Trigo, Ingrid Risso Patron, Agustina Rodriguez, Viviana Elizabeth |
author_sort | Garcia Allende, Natalia |
collection | PubMed |
description | BACKGROUND: End-of-treatment images of infections after intra-abdominal infection could increase costs. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are used to define and predict the evolution of infectious diseases. The aim of this study was to describe clinical outcomes of adult patients with end-of-treatment images or CRP and ESR follow-up, during treatment of organ/space (OS) (intra-abdominal) surgical site infection (SSI). METHODS: Observational retrospective cohort. Hospitalized patients older than 16 years were included, who developed OS SSI after abdominal surgery, in a general hospital, from June 2014 to June 2018. Population variables: age, gender, comorbidities (cancer, diabetes mellitus, cirrhosis, chronic renal failure, tobacco, immunosuppressants, Charlson score and obesity), ESR, quantitative CRP, imaging study (tomography (CT)/ ultrasound), type of drainage route (surgical, percutaneous). Outcomes variables: antibiotic patient-days, time to infection (TTI), CRP and ESR at the time of diagnosis (TD) and at the end of treatment (TET), rate of relapsing infection. Statistical analysis: Description of variables sort by patients under images follow-up and patients under CRP and ESR follow-up. Fisher test of relapsing infection was calculated between groups. RESULTS: Included: 76 patients. Twenty-six were followed with CT or ultrasound and 50 were followed with CRP and ESR. Forty women, with a mean age of 55 years (19–91) and an average score of the Charlson of 3.64 (0–10). Forty patients had cancer before surgery (52.63%). Microbiological diagnosis: 70/76 patients, the majority was polymicrobial. Average of antibiotics patient-days was 24.4 days (14 days of intravenous therapy). TTI: 8.65 days. Average CRP at the TD was 87.5 mg/L and 17.5 mg/L at TET. No differences in ESR values (31.9 mm to 33.5 mm). Percutaneous drainage: 46 patients. Surgical procedure: 27. Relapsing infection: 11,5% in images group vs. 4% in no images group; P = 0.33. CONCLUSION: Quantitative CRP monitoring was useful to guide the duration of antimicrobial treatment. No differences of relapsing infection between groups was found. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6808908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68089082019-10-28 1249. Images vs. C-Reactive Protein Follow-up of Patients with Organ/space Surgical Site Infections Garcia Allende, Natalia Freuler, Cristina Victoria Sanchez, Ana Ezcurra, Cecilia Mayer Wolf, Micaela Eliana Iglesias, Debora Paz, Sandra Antezana Trigo, Ingrid Risso Patron, Agustina Rodriguez, Viviana Elizabeth Open Forum Infect Dis Abstracts BACKGROUND: End-of-treatment images of infections after intra-abdominal infection could increase costs. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are used to define and predict the evolution of infectious diseases. The aim of this study was to describe clinical outcomes of adult patients with end-of-treatment images or CRP and ESR follow-up, during treatment of organ/space (OS) (intra-abdominal) surgical site infection (SSI). METHODS: Observational retrospective cohort. Hospitalized patients older than 16 years were included, who developed OS SSI after abdominal surgery, in a general hospital, from June 2014 to June 2018. Population variables: age, gender, comorbidities (cancer, diabetes mellitus, cirrhosis, chronic renal failure, tobacco, immunosuppressants, Charlson score and obesity), ESR, quantitative CRP, imaging study (tomography (CT)/ ultrasound), type of drainage route (surgical, percutaneous). Outcomes variables: antibiotic patient-days, time to infection (TTI), CRP and ESR at the time of diagnosis (TD) and at the end of treatment (TET), rate of relapsing infection. Statistical analysis: Description of variables sort by patients under images follow-up and patients under CRP and ESR follow-up. Fisher test of relapsing infection was calculated between groups. RESULTS: Included: 76 patients. Twenty-six were followed with CT or ultrasound and 50 were followed with CRP and ESR. Forty women, with a mean age of 55 years (19–91) and an average score of the Charlson of 3.64 (0–10). Forty patients had cancer before surgery (52.63%). Microbiological diagnosis: 70/76 patients, the majority was polymicrobial. Average of antibiotics patient-days was 24.4 days (14 days of intravenous therapy). TTI: 8.65 days. Average CRP at the TD was 87.5 mg/L and 17.5 mg/L at TET. No differences in ESR values (31.9 mm to 33.5 mm). Percutaneous drainage: 46 patients. Surgical procedure: 27. Relapsing infection: 11,5% in images group vs. 4% in no images group; P = 0.33. CONCLUSION: Quantitative CRP monitoring was useful to guide the duration of antimicrobial treatment. No differences of relapsing infection between groups was found. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6808908/ http://dx.doi.org/10.1093/ofid/ofz360.1112 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Garcia Allende, Natalia Freuler, Cristina Victoria Sanchez, Ana Ezcurra, Cecilia Mayer Wolf, Micaela Eliana Iglesias, Debora Paz, Sandra Antezana Trigo, Ingrid Risso Patron, Agustina Rodriguez, Viviana Elizabeth 1249. Images vs. C-Reactive Protein Follow-up of Patients with Organ/space Surgical Site Infections |
title | 1249. Images vs. C-Reactive Protein Follow-up of Patients with Organ/space Surgical Site Infections |
title_full | 1249. Images vs. C-Reactive Protein Follow-up of Patients with Organ/space Surgical Site Infections |
title_fullStr | 1249. Images vs. C-Reactive Protein Follow-up of Patients with Organ/space Surgical Site Infections |
title_full_unstemmed | 1249. Images vs. C-Reactive Protein Follow-up of Patients with Organ/space Surgical Site Infections |
title_short | 1249. Images vs. C-Reactive Protein Follow-up of Patients with Organ/space Surgical Site Infections |
title_sort | 1249. images vs. c-reactive protein follow-up of patients with organ/space surgical site infections |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808908/ http://dx.doi.org/10.1093/ofid/ofz360.1112 |
work_keys_str_mv | AT garciaallendenatalia 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT freulercristina 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT victoriasanchezana 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT ezcurracecilia 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT mayerwolfmicaela 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT elianaiglesiasdebora 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT pazsandra 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT antezanatrigoingrid 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT rissopatronagustina 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections AT rodriguezvivianaelizabeth 1249imagesvscreactiveproteinfollowupofpatientswithorganspacesurgicalsiteinfections |